GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Euroapi SA (LTS:0EAP) » Definitions » Other Current Liabilities

Euroapi (LTS:0EAP) Other Current Liabilities : €129.6 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Euroapi Other Current Liabilities?

Euroapi's other current liabilities for the quarter that ended in Dec. 2024 was €129.6 Mil.

Euroapi's quarterly other current liabilities increased from Dec. 2023 (€95.4 Mil) to Jun. 2024 (€109.4 Mil) and increased from Jun. 2024 (€109.4 Mil) to Dec. 2024 (€129.6 Mil).

Euroapi's annual other current liabilities declined from Dec. 2022 (€101.7 Mil) to Dec. 2023 (€95.4 Mil) but then increased from Dec. 2023 (€95.4 Mil) to Dec. 2024 (€129.6 Mil).


Euroapi Other Current Liabilities Historical Data

The historical data trend for Euroapi's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Euroapi Other Current Liabilities Chart

Euroapi Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Liabilities
Get a 7-Day Free Trial 98.60 191.70 101.70 95.40 129.60

Euroapi Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only 101.70 96.00 95.40 109.40 129.60

Euroapi Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


Euroapi Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Euroapi's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Euroapi Business Description

Traded in Other Exchanges
Address
15 rue Traversiere, Paris, FRA, 75012
Euroapi SA develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, and cosmetics. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. It also offers Contract Development Manufacturing Organization (CDMO) services to its customers. Geographically, the company generates maximum revenue from Europe, followed by North America, Asia-Pacific, and the Rest of the world.

Euroapi Headlines

No Headlines